Related Experiment Video
Updated: May 11, 2026
08:04
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Summary
This study investigates the roles of Shp1 and Shp2 phosphatases in blood cell development. Conditional knockout models reveal their importance in megakaryocyte development, platelet counts, and platelet size.
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- Protein tyrosine phosphatases (PTPs) play critical roles in cellular signaling pathways.
- Shp1 and Shp2 are key PTPs involved in regulating immune cell function and development.
- Dysregulation of PTPs can lead to hematological disorders.
Purpose of the Study:
- To investigate the specific roles of Shp1 and Shp2 in megakaryopoiesis and platelet production.
- To characterize the impact of Shp1 and Shp2 deficiency on platelet counts and size.
- To elucidate the function of Shp1 and Shp2 in platelet biology.
Main Methods:
- Generation and characterization of Shp1 and Shp2 conditional knockout murine models.
- Flow cytometry analysis of megakaryocyte precursors and platelets.
- Assessment of platelet aggregation and activation assays.
- Analysis of platelet counts and mean platelet volume (MPV).
Main Results:
- Conditional knockout of Shp1 and Shp2 significantly impacts megakaryocyte development.
- Shp1 and Shp2 deficiency leads to alterations in platelet counts and size.
- These phosphatases are crucial for maintaining normal platelet homeostasis.
- Specific roles of Shp1 and Shp2 in platelet function were elucidated.
Conclusions:
- Shp1 and Shp2 are essential regulators of megakaryocyte development and platelet production.
- Targeting Shp1 and Shp2 may offer therapeutic strategies for hematological disorders.
- Further research into PTPs in hematopoiesis is warranted.
Related Concept Videos
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:34Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...